{"transactions":[{"id":4614875,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":15626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":93756,"derivative":{"underlying":"Common stock","underlying_shares":15626},"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":4614874,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":6638,"price":8.7,"value":57750.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":595447,"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":4614873,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-10T21:01:32.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":15626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":602085,"source":{"system":"sec-edgar","filing":"0001104659-26-106752","document":"tm2625111-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926106752/tm2625111-3_4seq1.xml","form_type":"4"}},{"id":3039,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":83338,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":3038,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":17702,"price":8.28,"value":146572.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":586459,"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":3037,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-03T21:02:48.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":604161,"source":{"system":"sec-edgar","filing":"0001104659-26-105101","document":"tm2624648-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926105101/tm2624648-3_4seq1.xml","form_type":"4"}},{"id":744697,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":109382,"derivative":{"underlying":"Common stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":744696,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6638,"price":4.23,"value":28078.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":562492,"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":744695,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-09T17:03:00.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":569130,"source":{"system":"sec-edgar","filing":"0001104659-26-071899","document":"tm2617137-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926071899/tm2617137-4_4seq1.xml","form_type":"4"}},{"id":751833,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":125007,"derivative":{"underlying":"Common stock","underlying_shares":41668},"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":751832,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":17701,"price":3.96,"value":70095.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":553505,"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":751831,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-06-03T21:02:06.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":571206,"source":{"system":"sec-edgar","filing":"0001104659-26-070155","document":"tm2616710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926070155/tm2616710-4_4seq1.xml","form_type":"4"}},{"id":848711,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:07:57.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":235000,"derivative":{"underlying":"Common stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0001104659-26-026457","document":"tm268453-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926026457/tm268453-6_4seq1.xml","form_type":"4"}},{"id":855954,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":62493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":125007,"derivative":{"underlying":"Common stock","underlying_shares":62493},"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":855953,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":26755,"price":4.58,"value":122537.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":529538,"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":855952,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T22:02:10.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":62493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":556293,"source":{"system":"sec-edgar","filing":"0001104659-26-024765","document":"tm268187-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926024765/tm268187-4_4seq1.xml","form_type":"4"}},{"id":861656,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":10418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":10418},"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861655,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":166675,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861654,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":22809,"price":3.79,"value":86446.11,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":493800,"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":861653,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T22:01:44.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":52087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":516609,"source":{"system":"sec-edgar","filing":"0001104659-26-023539","document":"tm267902-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465926023539/tm267902-4_4seq1.xml","form_type":"4"}},{"id":981599,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-02","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":10418,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":981598,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":208344,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":981597,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4426,"price":2.14,"value":9471.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":464522,"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":981596,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-02","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":468948,"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":981595,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":17701,"price":2.23,"value":39473.23,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":458531,"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":981594,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T22:01:35.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":476232,"source":{"system":"sec-edgar","filing":"0001104659-25-118168","document":"tm2532666-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925118168/tm2532666-2_4seq1.xml","form_type":"4"}},{"id":1047991,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-09-04T22:35:27.000Z","date":"2025-09-02","kind":"exercise","planned":false,"acquired":false,"shares":41669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":250013,"derivative":{"underlying":"Common stock","underlying_shares":41669},"source":{"system":"sec-edgar","filing":"0001104659-25-087549","document":"tm2525186-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925087549/tm2525186-4_4seq1.xml","form_type":"4"}},{"id":1047990,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-09-04T22:35:27.000Z","date":"2025-09-02","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":20385,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-25-087549","document":"tm2525186-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925087549/tm2525186-4_4seq1.xml","form_type":"4"}},{"id":1047989,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-09-04T22:35:27.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":22127,"price":2.19,"value":48458.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":434563,"source":{"system":"sec-edgar","filing":"0001104659-25-087549","document":"tm2525186-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925087549/tm2525186-4_4seq1.xml","form_type":"4"}},{"id":1047988,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-09-04T22:35:27.000Z","date":"2025-09-02","kind":"exercise","planned":false,"acquired":true,"shares":52086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":456690,"source":{"system":"sec-edgar","filing":"0001104659-25-087549","document":"tm2525186-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925087549/tm2525186-4_4seq1.xml","form_type":"4"}},{"id":1122966,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T20:50:32.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":41668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":291682,"derivative":{"underlying":"Common stock","underlying_shares":41668},"source":{"system":"sec-edgar","filing":"0001104659-25-056440","document":"tm2517077-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925056440/tm2517077-4_4seq1.xml","form_type":"4"}},{"id":1122965,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T20:50:32.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":31252,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-25-056440","document":"tm2517077-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925056440/tm2517077-4_4seq1.xml","form_type":"4"}},{"id":1122964,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-06-04T20:50:32.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":22127,"price":1.76,"value":38943.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":404604,"source":{"system":"sec-edgar","filing":"0001104659-25-056440","document":"tm2517077-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925056440/tm2517077-4_4seq1.xml","form_type":"4"}},{"id":1122963,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-06-04T20:50:32.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":52085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":426731,"source":{"system":"sec-edgar","filing":"0001104659-25-056440","document":"tm2517077-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925056440/tm2517077-4_4seq1.xml","form_type":"4"}},{"id":1145437,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-05-16T20:05:18.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.69,"value":42250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024."}],"balance_after":374646,"source":{"system":"sec-edgar","filing":"0001104659-25-049999","document":"tm2515393-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925049999/tm2515393-1_4seq1.xml","form_type":"4"}},{"id":1217475,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-08T01:06:49.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":187500,"derivative":{"underlying":"Common stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001104659-25-021872","document":"tm258333-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925021872/tm258333-10_4seq1.xml","form_type":"4"}},{"id":1222544,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:32:01.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":213525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":333350,"derivative":{"underlying":"Common stock","underlying_shares":213525},"source":{"system":"sec-edgar","filing":"0001104659-25-021057","document":"tm258333-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925021057/tm258333-3_4seq1.xml","form_type":"4"}},{"id":1222543,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:32:01.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":10418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":41669,"derivative":{"underlying":"Common stock","underlying_shares":10418},"source":{"system":"sec-edgar","filing":"0001104659-25-021057","document":"tm258333-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925021057/tm258333-3_4seq1.xml","form_type":"4"}},{"id":1222542,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T01:32:01.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":95413,"price":4.04,"value":385468.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":349646,"source":{"system":"sec-edgar","filing":"0001104659-25-021057","document":"tm258333-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925021057/tm258333-3_4seq1.xml","form_type":"4"}},{"id":1222541,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T01:32:01.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":223943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":445059,"source":{"system":"sec-edgar","filing":"0001104659-25-021057","document":"tm258333-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925021057/tm258333-3_4seq1.xml","form_type":"4"}},{"id":1301533,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-01-16T23:01:36.000Z","date":"2025-01-14","kind":"exercise","planned":false,"acquired":false,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":20835},"source":{"system":"sec-edgar","filing":"0001104659-25-004205","document":"tm253469-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925004205/tm253469-3_4seq1.xml","form_type":"4"}},{"id":1301532,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-01-16T23:01:36.000Z","date":"2025-01-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":9955,"price":5.89,"value":58634.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":221116,"source":{"system":"sec-edgar","filing":"0001104659-25-004205","document":"tm253469-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925004205/tm253469-3_4seq1.xml","form_type":"4"}},{"id":1301531,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2025-01-16T23:01:36.000Z","date":"2025-01-14","kind":"exercise","planned":false,"acquired":true,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":231071,"source":{"system":"sec-edgar","filing":"0001104659-25-004205","document":"tm253469-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465925004205/tm253469-3_4seq1.xml","form_type":"4"}},{"id":1342997,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-12-04T21:31:00.000Z","date":"2024-12-02","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":52087,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-24-125547","document":"tm2430163-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924125547/tm2430163-3_4seq1.xml","form_type":"4"}},{"id":1342996,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-12-04T21:31:00.000Z","date":"2024-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4426,"price":9.07,"value":40143.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":210236,"source":{"system":"sec-edgar","filing":"0001104659-24-125547","document":"tm2430163-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924125547/tm2430163-3_4seq1.xml","form_type":"4"}},{"id":1342995,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-12-04T21:31:00.000Z","date":"2024-12-02","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":214662,"source":{"system":"sec-edgar","filing":"0001104659-24-125547","document":"tm2430163-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924125547/tm2430163-3_4seq1.xml","form_type":"4"}},{"id":1385884,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-10-16T22:33:29.000Z","date":"2024-10-14","kind":"exercise","planned":false,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person."}],"balance_after":20835,"derivative":{"underlying":"Common stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001104659-24-109279","document":"tm2426276-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924109279/tm2426276-3_4seq1.xml","form_type":"4"}},{"id":1385883,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-10-16T22:33:29.000Z","date":"2024-10-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":9.77,"value":86474.27,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":204245,"source":{"system":"sec-edgar","filing":"0001104659-24-109279","document":"tm2426276-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924109279/tm2426276-3_4seq1.xml","form_type":"4"}},{"id":1385882,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-10-16T22:33:29.000Z","date":"2024-10-14","kind":"exercise","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":213096,"source":{"system":"sec-edgar","filing":"0001104659-24-109279","document":"tm2426276-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924109279/tm2426276-3_4seq1.xml","form_type":"4"}},{"id":1413991,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The remaining RSUs will vest on the one-year anniversary of the initial grant date, as provided in footnote 8."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The remaining RSUs will vest on the one-year anniversary of the initial grant date, as provided in footnote 8."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":46875,"derivative":{"underlying":"Common Stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1413990,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":62504,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1413989,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":19913,"price":10.85,"value":216056.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":192262,"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1413988,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":212175,"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1413987,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4426,"price":10.85,"value":48022.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":165300,"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1413986,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-09-05T23:56:04.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":169726,"source":{"system":"sec-edgar","filing":"0001104659-24-097491","document":"tm2423453-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924097491/tm2423453-4_4seq1.xml","form_type":"4"}},{"id":1452631,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-07-18T00:01:35.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":false,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person."}],"balance_after":41669,"derivative":{"underlying":"Common stock","underlying_shares":20835},"source":{"system":"sec-edgar","filing":"0001104659-24-080619","document":"tm2419709-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924080619/tm2419709-3_4seq1.xml","form_type":"4"}},{"id":1452630,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-07-18T00:01:35.000Z","date":"2024-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":8.68,"value":76826.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":159309,"source":{"system":"sec-edgar","filing":"0001104659-24-080619","document":"tm2419709-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924080619/tm2419709-3_4seq1.xml","form_type":"4"}},{"id":1452629,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-07-18T00:01:35.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":true,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":168160,"source":{"system":"sec-edgar","filing":"0001104659-24-080619","document":"tm2419709-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924080619/tm2419709-3_4seq1.xml","form_type":"4"}},{"id":1490099,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-06-06T00:04:19.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":72921,"derivative":{"underlying":"Common stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001104659-24-068771","document":"tm2416581-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924068771/tm2416581-1_4seq1.xml","form_type":"4"}},{"id":1490098,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-06-06T00:04:19.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4426,"price":8.37,"value":37045.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":147325,"source":{"system":"sec-edgar","filing":"0001104659-24-068771","document":"tm2416581-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924068771/tm2416581-1_4seq1.xml","form_type":"4"}},{"id":1490097,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-06-06T00:04:19.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":151751,"source":{"system":"sec-edgar","filing":"0001104659-24-068771","document":"tm2416581-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924068771/tm2416581-1_4seq1.xml","form_type":"4"}},{"id":1540024,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-04-17T23:08:54.000Z","date":"2024-04-15","kind":"exercise","planned":false,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person."}],"balance_after":62504,"derivative":{"underlying":"Common stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001104659-24-048429","document":"tm2412101-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924048429/tm2412101-3_4seq1.xml","form_type":"4"}},{"id":1540023,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-04-17T23:08:54.000Z","date":"2024-04-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":11.89,"value":105238.39,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":141334,"source":{"system":"sec-edgar","filing":"0001104659-24-048429","document":"tm2412101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924048429/tm2412101-3_4seq1.xml","form_type":"4"}},{"id":1540022,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-04-17T23:08:54.000Z","date":"2024-04-15","kind":"exercise","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":150185,"source":{"system":"sec-edgar","filing":"0001104659-24-048429","document":"tm2412101-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924048429/tm2412101-3_4seq1.xml","form_type":"4"}},{"id":1591766,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T23:19:03.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":41662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person."}],"balance_after":83338,"derivative":{"underlying":"Common stock","underlying_shares":41662},"source":{"system":"sec-edgar","filing":"0001104659-24-031576","document":"tm248073-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924031576/tm248073-2_4seq1.xml","form_type":"4"}},{"id":1591765,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T23:19:03.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11449,"price":16.96,"value":194175.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":129351,"source":{"system":"sec-edgar","filing":"0001104659-24-031576","document":"tm248073-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924031576/tm248073-2_4seq1.xml","form_type":"4"}},{"id":1591764,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T23:19:03.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":41662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":140800,"source":{"system":"sec-edgar","filing":"0001104659-24-031576","document":"tm248073-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924031576/tm248073-2_4seq1.xml","form_type":"4"}},{"id":1596604,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T22:56:15.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant."}],"balance_after":93750,"derivative":{"underlying":"Common stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001104659-24-031113","document":"tm248017-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924031113/tm248017-9_4seq1.xml","form_type":"4"}},{"id":1596603,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T22:56:15.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":500000,"derivative":{"underlying":"Common stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-031113","document":"tm248017-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924031113/tm248017-9_4seq1.xml","form_type":"4"}},{"id":1676447,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-01-18T23:09:35.000Z","date":"2024-01-16","kind":"exercise","planned":false,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."}],"balance_after":83338,"derivative":{"underlying":"Common stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001104659-24-004866","document":"tm243610-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924004866/tm243610-3_4seq1.xml","form_type":"4"}},{"id":1676446,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T23:09:35.000Z","date":"2024-01-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":6530,"price":8.37,"value":54656.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":99138,"source":{"system":"sec-edgar","filing":"0001104659-24-004866","document":"tm243610-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924004866/tm243610-3_4seq1.xml","form_type":"4"}},{"id":1676445,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T23:09:35.000Z","date":"2024-01-16","kind":"exercise","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":105668,"source":{"system":"sec-edgar","filing":"0001104659-24-004866","document":"tm243610-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465924004866/tm243610-3_4seq1.xml","form_type":"4"}},{"id":1758163,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-10-19T00:05:09.000Z","date":"2023-10-16","kind":"exercise","planned":false,"acquired":false,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in five equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in five equal quarterly installments."}],"balance_after":104172,"derivative":{"underlying":"Common stock","underlying_shares":20835},"source":{"system":"sec-edgar","filing":"0001104659-23-109942","document":"tm2328751-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923109942/tm2328751-3_4seq1.xml","form_type":"4"}},{"id":1758162,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-10-19T00:05:09.000Z","date":"2023-10-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":3.57,"value":31598.07,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":84834,"source":{"system":"sec-edgar","filing":"0001104659-23-109942","document":"tm2328751-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923109942/tm2328751-3_4seq1.xml","form_type":"4"}},{"id":1758161,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-10-19T00:05:09.000Z","date":"2023-10-16","kind":"exercise","planned":false,"acquired":true,"shares":20835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":93685,"source":{"system":"sec-edgar","filing":"0001104659-23-109942","document":"tm2328751-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923109942/tm2328751-3_4seq1.xml","form_type":"4"}},{"id":1828735,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-07-17T22:22:13.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in six equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in six equal quarterly installments."}],"balance_after":125007,"derivative":{"underlying":"Common stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001104659-23-081715","document":"tm2321428-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923081715/tm2321428-3_4seq1.xml","form_type":"4"}},{"id":1828734,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-07-17T22:22:13.000Z","date":"2023-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":7.76,"value":68683.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":72850,"source":{"system":"sec-edgar","filing":"0001104659-23-081715","document":"tm2321428-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923081715/tm2321428-3_4seq1.xml","form_type":"4"}},{"id":1828733,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-07-17T22:22:13.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":81701,"source":{"system":"sec-edgar","filing":"0001104659-23-081715","document":"tm2321428-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923081715/tm2321428-3_4seq1.xml","form_type":"4"}},{"id":1918153,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-04-18T21:50:07.000Z","date":"2023-04-14","kind":"exercise","planned":false,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in seven equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in seven equal quarterly installments."}],"balance_after":145841,"derivative":{"underlying":"Common stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001104659-23-046844","document":"tm2313085-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923046844/tm2313085-3_4seq1.xml","form_type":"4"}},{"id":1918152,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-04-18T21:50:07.000Z","date":"2023-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8851,"price":5.64,"value":49919.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":60867,"source":{"system":"sec-edgar","filing":"0001104659-23-046844","document":"tm2313085-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923046844/tm2313085-3_4seq1.xml","form_type":"4"}},{"id":1918151,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-04-18T21:50:07.000Z","date":"2023-04-14","kind":"exercise","planned":false,"acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"20,834 of the restricted stock units (\"RSUs\") issued to the Reporting Person on January 14, 2022 vested and settled on April 14, 2023."}],"balance_after":69718,"source":{"system":"sec-edgar","filing":"0001104659-23-046844","document":"tm2313085-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923046844/tm2313085-3_4seq1.xml","form_type":"4"}},{"id":1969207,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T22:27:21.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":500000,"derivative":{"exercise_price":7.12,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-23-029101","document":"tm238642-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923029101/tm238642-4_4seq1.xml","form_type":"4"}},{"id":1969206,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-03-06T22:27:21.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":125000,"derivative":{"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-23-029101","document":"tm238642-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923029101/tm238642-4_4seq1.xml","form_type":"4"}},{"id":2050934,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-01-19T21:51:13.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":83325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in eight equal quarterly installments over the next two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in eight equal quarterly installments over the next two years."}],"balance_after":166675,"derivative":{"underlying":"Common stock","underlying_shares":83325},"source":{"system":"sec-edgar","filing":"0001104659-23-005045","document":"tm233853d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923005045/tm233853d1_4seq1.xml","form_type":"4"}},{"id":2050933,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-01-19T21:51:13.000Z","date":"2023-01-17","kind":"tax_withholding","acquired":false,"shares":36441,"price":6.43,"value":234315.63,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":48884,"source":{"system":"sec-edgar","filing":"0001104659-23-005045","document":"tm233853d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923005045/tm233853d1_4seq1.xml","form_type":"4"}},{"id":2050932,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2023-01-19T21:51:13.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":83325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"One-third of the restricted stock units (\"RSUs\") issued to the Reporting Person on January 14, 2022, vested on January 14, 2023. The vested RSUs were settled on January 17, 2023."}],"balance_after":85325,"source":{"system":"sec-edgar","filing":"0001104659-23-005045","document":"tm233853d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465923005045/tm233853d1_4seq1.xml","form_type":"4"}},{"id":2103407,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2022-11-29T02:46:19.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":1000,"price":5.98,"value":5980.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-22-122556","document":"tm2231429-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465922122556/tm2231429-2_4seq1.xml","form_type":"4"}},{"id":2247669,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Common Stock","published_at":"2022-06-03T00:00:41.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":1000,"price":6.44,"value":6440.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-22-067758","document":"tm2217576d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465922067758/tm2217576d2_4seq1.xml","form_type":"4"}},{"id":2432363,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-01-20T01:32:24.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-22-005599","document":"tm223806-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465922005599/tm223806-4_4seq1.xml","form_type":"4"}},{"id":2666412,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:06:07.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":73900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-half of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest on December 31, 2022."}],"balance_after":73900,"derivative":{"exercise_price":23.87,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":73900},"source":{"system":"sec-edgar","filing":"0001104659-21-082064","document":"tm2119923-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465921082064/tm2119923-1_4seq1.xml","form_type":"4"}},{"id":2666411,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:06:07.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":23.87,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-082064","document":"tm2119923-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465921082064/tm2119923-1_4seq1.xml","form_type":"4"}},{"id":2916001,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T22:00:25.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":175000,"derivative":{"exercise_price":46.26,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-21-001571","document":"tm211898-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465921001571/tm211898-1_4seq1.xml","form_type":"4"}},{"id":3316497,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-08T02:00:47.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 150,000 shares shall vest on the one-year anniversary of January 3, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of January 3, 2020."}],"balance_after":150000,"derivative":{"exercise_price":25.54,"expiration_date":"2030-01-02","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-002088","document":"tm201473d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000110465920002088/tm201473d3_4.xml","form_type":"4"}},{"id":3608598,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-06T22:00:40.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 200,000 shares shall vest on the one-year anniversary of March 4, 2019; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of March 4, 2019."}],"balance_after":200000,"derivative":{"exercise_price":11.26,"expiration_date":"2019-03-04","underlying":"Common stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-19-012580","document":"tv515608_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000114420419012580/tv515608_4.xml","form_type":"4"}},{"id":4104353,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":2103,"kind":"person","name":"Vogt Frederick G","position":1,"cik":"0001719678","reported_name":"Vogt Frederick G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-08T18:30:55.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":37400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 37,400 shares shall vest on the one-year anniversary of December 29, 2017; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of December 29, 2017."}],"balance_after":37400,"derivative":{"exercise_price":8,"expiration_date":"2027-12-28","underlying":"Common Stock","underlying_shares":37400},"source":{"system":"sec-edgar","filing":"0001250853-18-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719678/000125085318000014/primary_doc.xml","form_type":"4"}}]}